Publications by authors named "Benjamin Freemyer"

6 Publications

  • Page 1 of 1

Granular cell tumor: importance of histopathology in determining malignant potential.

Dermatol Online J 2021 May 15;27(5). Epub 2021 May 15.

Department of Dermatology, University of Texas Health Science Center at Houston, Houston, TX.

Granular cell tumors (GCTs), sometimes called Abrikossoff tumors, are rare and typically benign soft tissue tumors. Malignant GCTs, which are even rarer than benign GCTs, can occur and must be detected early given their high mortality rate. Distinguishing between benign and malignant GCTs is difficult clinically; however, histologic evaluation plays an essential role in this endeavor.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.5070/D327553617DOI Listing
May 2021

Linear terra firma-forme dermatosis of the midline back.

Cutis 2018 Mar;101(3):205-206

Department of Dermatology, McGovern Medical School, University of Texas, Houston, USA.

Terra firma-forme dermatosis (TFFD) is a benign and likely underdiagnosed disorder with relatively few reports in the literature. A 46-year-old woman presented to our clinic with a 3-year history of linear TFFD extending from the upper sacrum to the midline upper back. It initially was thought to be acanthosis nigricans or lichen simplex chronicus, and a topical steroid cream was applied without success. The lesion ultimately was removed by rubbing with isopropyl alcohol, which confirmed a diagnosis of TFFD. Due to its ability to mimic other skin diseases, TFFD should be considered when patients present with hyperkeratotic hyperpigmented lesions.
View Article and Find Full Text PDF

Download full-text PDF

Source
March 2018

A cross-sectional study of YouTube videos about atopic dermatitis.

J Am Acad Dermatol 2018 03;78(3):612-613

Department of Dermatology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2017.09.005DOI Listing
March 2018

Ethical challenges with treating nonadherent patients in a group practice setting.

J Am Acad Dermatol 2018 Sep 14;79(3):596-598. Epub 2017 Oct 14.

Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia; Emory Center for Ethics, Emory University, Atlanta, Georgia.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2017.10.009DOI Listing
September 2018

Treatment outcomes in pediatric melanoma-Are there benefits to specialized care?

J Pediatr Surg 2016 Dec 17;51(12):2063-2067. Epub 2016 Sep 17.

Department of Pediatric Surgery, The McGovern Medical School at the University of Texas Health Science Center at Houston, 6431 Fannin Street, Suite 5.258, Houston, TX 77030; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1400 Pressler, Unit 1484, Houston, TX 77030. Electronic address:

Purpose: The purpose of this study was to evaluate the impact of hospital specialization on survival in pediatric melanoma.

Methods: We reviewed all patients under 18years old with cutaneous melanoma evaluated at MD Anderson Cancer Center, a National Cancer Institute (NCI)-designated center, from 2000 to 2014. We compared overall survival (OS) and disease-free survival (DFS) between patients who underwent all treatments at MDACC (Group A, n=146) and those who underwent initial surgical treatment at a non-NCI center (Group B, n=58). Kaplan-Meier survival curves were compared using the log-rank test.

Results: Group A patients had significantly better OS and DFS (both p<0.001). Five-year OS was 97% (95% CI 92%-99%) in Group A versus 88% (95% CI 74%-94%) in Group B. Group survival differences were most notable in Stage 3 and 4 patients. Group A patients presenting with stage III or IV disease had a 5-year OS rate of 91.2% (95% CI 75.1%-97.1%) compared to 80.8% (95% CI 59.8%-91.5%) in Group B. The DFS rate was 94.4% (95% CI 88.5%-97.3%) in Group A versus 77.2% (95% CI 62.5%-86.7%) in Group B.

Conclusion: Surgical treatment at a comprehensive cancer center may improve outcomes for pediatric melanoma especially for patients presenting with later stage disease.

Level Of Evidence: Case-control study: Level III.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpedsurg.2016.09.039DOI Listing
December 2016
-->